1-hydroxy-3-amino-2-pyrrolidone has been researched along with Morphine Abuse in 4 studies
1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, F | 1 |
| Dufour, E | 1 |
| Le Bars, D | 1 |
| Kosten, TA | 1 |
| DeCaprio, JL | 1 |
| Rosen, MI | 1 |
| Bristow, LJ | 1 |
| Hogg, JE | 1 |
| Hutson, PH | 1 |
| Christensen, D | 1 |
| Guilbaud, G | 1 |
| Kayser, V | 1 |
4 other studies available for 1-hydroxy-3-amino-2-pyrrolidone and Morphine Abuse
| Article | Year |
|---|---|
The glycine site-specific NMDA antagonist (+)-HA966 enhances the effect of morphine and reverses morphine tolerance via a spinal mechanism.
Topics: Animals; Dose-Response Relationship, Radiation; Drug Tolerance; Electric Stimulation; Electromyograp | 2008 |
The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist.
Topics: Animals; Anticonvulsants; Cycloserine; Excitatory Amino Acid Antagonists; Felbamate; Male; Morphine; | 1995 |
Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Binding, Competitive; Clonidine | 1997 |
The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Topics: Animals; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Morphine; Morphi | 2000 |